## GM: General Motors Company - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 2.8% below STRENGTH zone (4.0-10.0%); PEG 1.89 fails VALUE criteria (<1.0); RSI 72 overbought. Stock is in no-man's land without clear edge. Caution: declining volume (39% of avg), momentum weakening (-2.2% MRS), overbought RSI (72).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($79.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. General Motors (NYSE: GM) Price Prediction and Forecast 2026-2030 (January 2026)**
- Source: 24/7 Wall St. | 20251230T145255 | Somewhat-Bullish | Relevance: 100%
- This article provides a General Motors (NYSE: GM) stock price prediction and forecast for 2026-2030, detailing key drivers such as electrification, partnerships, and R&D efforts. It analyzes GM's recent stock performance, highlighting its multi-month win streak and significant investments in both EV and traditional V8 engine production. The report also includes financial data, analyst ratings, and 24/7 Wall St.'s own price targets, acknowledging potential downsides due to legal issues and political stances on EVs.

**2. General Motors Outperforms Rivals in 2025 Amid Strong Earnings and Market Gains**
- Source: International Business Times | 20251230T075100 | Bullish | Relevance: 100%
- General Motors (GM) is closing 2025 as the top-performing US-traded automaker stock, significantly outperforming competitors like Ford, Tesla, and Stellantis. The company's shares reached a record high above $80, marking over 55% growth for the year and its strongest performance since 2009, driven by strong earnings, shareholder returns, and favorable market conditions. Analysts attribute GM's success to its disciplined strategy in unit sales growth, increasing average transaction prices, and effective inventory management.

**3. General Motors stock on track to beat auto rivals like Tesla, Ford in 2025**
- Source: New York Post | 20251229T235122 | Bullish | Relevance: 100%
- General Motors is set to finish 2025 as the leading US-traded automaker stock, outperforming competitors such as Ford, Tesla, and Stellantis. The stock has surged over 55% this year to a record high, driven by strong earnings and anticipation of favorable policies from the Trump administration. Analysts maintain high expectations, with UBS and Morgan Stanley raising price targets, as GM plans further stock buybacks due to perceived undervaluation.

**4. Permanent Capital Management LP Invests $1.10 Million in General Motors Company $GM**
- Source: MarketBeat | 20251229T110809 | Somewhat-Bullish | Relevance: 100%
- Permanent Capital Management LP has acquired a new stake of 18,067 shares in General Motors, valued at approximately $1.10 million. This investment comes as institutional investors now own about 92.67% of GM's stock, and several analysts have upgraded the company's rating. General Motors recently exceeded Q3 earnings expectations and provided strong FY2025 guidance.

**5. GM's record stock performance beats Tesla, Ford and other automakers in 2025**
- Source: CNBC | 20251229T082400 | Bullish | Relevance: 100%
- General Motors (GM) is set to be the top U.S.-traded automaker stock of 2025, with shares up over 55% to a record high, surpassing Tesla, Ford, and Stellantis. This performance is attributed to strong cash generation, earnings resilience, and shareholder returns, as well as external factors like relaxed government regulations. CEO Mary Barra has sold a significant number of shares this year, valued at over $73 million, but retains a substantial stake in the company.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Wedbush | $95 | $75 | +27% |
| 2025-12-15 | UBS | $97 | $85 | +14% |
| 2025-12-09 | Wells Fargo | $48 | $46 | +4% |
| 2025-12-09 | Goldman Sachs | $93 | $81 | +15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Wedbush | main | Outperform |
| 2025-12-15 | UBS | main | Buy |
| 2025-12-09 | Wells Fargo | main | Underweight |
| 2025-12-09 | Goldman Sachs | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.78M) |
| Sells | 2 ($0.56M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-1.1%)
- Blackrock Inc.: 9.4% (+1.9%)
- State Street Corpora: 5.0% (-4.3%)
- Franklin Resources, : 3.4% (+3.3%)
- Greenhaven Associate: 2.5% (-2.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.2% 5d) with bearish MACD, trend may be turning.
2. Overbought RSI (72) with bearish MACD signals exhaustion.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 5 raises (avg +25%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.89 elevated, pricing in significant growth expectations. Forward P/E 7.1x attractive for 13% earnings growth. Balance sheet: $5.0B free cash flow. Analyst sentiment positive (5 raises, avg +25%). Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $78.4B |
| Beta | 1.30 |
| 52W Range | $41.60 - $83.68 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.89 |
| Forward P/E | 7.1 |
| Current P/E | 8.0 |
| YoY Growth | 13.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.0% to 2.8% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.2pp (needs >4.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. Outperforming sector by 3.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion. Volume at 39% of 20MA suggests lack of conviction. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.82% (CS: 86) | Neutral |
| RSI_14 | 71.7 | Overbought |
| MACD Histogram | -0.20 | Bearish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.119x | Above |
| vs SMA200 | 1.435x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $82.35
- **Stop Loss:** $79.65 (3.3% risk)
- **Target:** $85.05 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 407
- **Position Value:** $33,516.45
- **Portfolio %:** 33.52%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-27 (Est: $2.19)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.32 | $2.80 | +20.5% |
| 2025Q2 | $2.48 | $2.53 | +2.1% |
| 2025Q1 | $2.67 | $2.78 | +4.3% |
| 2024Q4 | $1.84 | $1.92 | +4.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*